Helena Florindo was distinguished, on May 20th 2020, with the “CRS Immuno Delivery Young Investigator Award 2020”. This international award, attributed by the Focus Group on Immunology of the international Controlled Release Society (CRS), recognizes a current Controlled Release Society member, who has made outstanding contributions in the science of controlled release. The distinction falls on the work that the FFUL Teaching Staff and Researcher – and a Board member of the Focus Group Nanomedicine and Nanoscale Delivery of CRS – has been developing in the context of a nanovacine for the remodeling of the immune response against cancer.
The effectiveness of this innovation (carried out in partnership with the University of Tel Aviv) is still in an experimental phase, showing so far that this nanovacine induces the immune system to destroy cancer cells and control the development of the disease.
Following the award, Helena Florindo will present, on June 30th 2020, the project “Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators” at the annual (online) meeting of CRS.
